Abstract
Purpose
To compare the efficacy of a transdermal buprenorphine patch (5, 10, 15, and 20 μg/h) with that of oral tramadol (150, 200, 250, and 300 mg) for postoperative pain control after single level spinal fusion surgery.
Methods
The present study (ClinicalTrials.gov, number NCT02416804) was a prospective, randomized controlled non-inferiority trial designed to determine the efficacy of buprenorphine TDS for alleviating postoperative pain following patient controlled analgesia (PCA) in persons underwent a single level posterior lumbar interbody fusion surgery through 1:1 allocation. The primary outcome was the Visual Analog Pain Scale (VAS) score for postoperative back pain at 7 days after surgery. The non-inferior margin of the VAS was set at δ = 1.5 points.
Results
The VAS score (primary outcome) for postoperative back pain at 7 days after surgery in the Buprenorphine group was not inferior compared to the Tramadol group. The overall changes in VAS scores for postoperative pain during follow-up assessments over a 2-week period did not differ between both groups. However, the VAS scores for postoperative pain significantly improved with time after surgery in both groups. The patterns of changes in the VAS scores for postoperative pain during the follow-up period were not significantly different between the both groups.
Conclusions
The efficacy of buprenorphine TDS was not inferior to that of oral tramadol medication for alleviating postoperative pain in the subacute period from 72 h after surgery, following PCA administration. In addition, adverse events were similar between both groups.
Similar content being viewed by others
References
Katz J, Poleshuck EL, Andrus CH, Hogan LA, Jung BF, Kulick DI, Dworkin RH (2005) Risk factors for acute pain and its persistence following breast cancer surgery. Pain 119(1–3):16–25
Perkins FM, Kehlet H (2000) Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology 93(4):1123–1133
Kehlet H, Holte K (2001) Effect of postoperative analgesia on surgical outcome. Br J Anaesth 87(1):62–72
Ballantyne JC, Carr DB, deFerranti S, Suarez T, Lau J, Chalmers TC, Angelillo IF, Mosteller F (1998) The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg 86(3):598–612
Tsui SL, Law S, Fok M, Lo JR, Ho E, Yang J, Wong J (1997) Postoperative analgesia reduces mortality and morbidity after esophagectomy. Am J Surg 173(6):472–478
Lundblad H, Kreicbergs A, Jansson KA (2008) Prediction of persistent pain after total knee replacement for osteoarthritis. J Bone Jt Surg Br 90(2):166–171
Kehlet H, Jensen TS, Woolf CJ (2006) Persistent postsurgical pain: risk factors and prevention. Lancet 367(9522):1618–1625. doi:10.1016/s0140-6736(06)68700-x
Hiller A, Helenius I, Nurmi E, Neuvonen PJ, Kaukonen M, Hartikainen T, Korpela R, Taivainen T, Meretoja OA (2012) Acetaminophen improves analgesia but does not reduce opioid requirement after major spine surgery in children and adolescents. Spine (Phila Pa 1976) 37(20):E1225–E1231. doi:10.1097/BRS.0b013e318263165c
Jirarattanaphochai K, Jung S, Thienthong S, Krisanaprakornkit W, Sumananont C (2007) Peridural methylprednisolone and wound infiltration with bupivacaine for postoperative pain control after posterior lumbar spine surgery: a randomized double-blinded placebo-controlled trial. Spine (Phila Pa 1976) 32(6):609–616. doi:10.1097/01.brs.0000257541.91728.a1 (discussion 617)
Sekar C, Rajasekaran S, Kannan R, Reddy S, Shetty TA, Pithwa YK (2004) Preemptive analgesia for postoperative pain relief in lumbosacral spine surgeries: a randomized controlled trial. Spine J 4(3):261–264
Lindley EM, Milligan K, Farmer R, Burger EL, Patel VV (2015) Patient-controlled transdermal fentanyl versus intravenous morphine pump after spine surgery. Orthopedics 38(9):e819–e824. doi:10.3928/01477447-20150902-61
Kumar S, Chaudhary AK, Singh PK, Verma R, Chandra G, Bhatia VK, Singh D, Bogra J (2016) Transdermal Buprenorphine Patches for Postoperative Pain Control in Abdominal Surgery. J Clin Diagn Res JCDR 10(6):Uc05-08. doi:10.7860/jcdr/2016/18152.7982
Plosker GL (2011) Buprenorphine 5, 10 and 20 mug/h transdermal patch: a review of its use in the management of chronic non-malignant pain. Drugs 71(18):2491–2509. doi:10.2165/11208250-000000000-00000
Karlsson M, Berggren AC (2009) Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study. Clin Ther 31(3):503–513. doi:10.1016/j.clinthera.2009.03.001
Kapil RP, Cipriano A, Friedman K, Michels G, Shet MS, Colucci SV, Apseloff G, Kitzmiller J, Harris SC (2013) Once-weekly transdermal buprenorphine application results in sustained and consistent steady-state plasma levels. J Pain Symptom Manag 46(1):65–75. doi:10.1016/j.jpainsymman.2012.06.014
Group TE (1990) EuroQol—a new facility for the measurement of health-related quality of life. Health Policy (Amsterdam, Netherlands) 16(3):199–208
Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26(11):1261–1268. doi:10.1038/nbt.1504
Pota V, Barbarisi M, Sansone P, Moraci M, Pace MC, Passavanti MB, Aurilio C (2012) Combination therapy with transdermal buprenorphine and pregabalin for chronic low back pain. Pain Manag 2(1):23–31. doi:10.2217/pmt.11.71
Kitzmiller JP, Barnett CJ, Steiner NS, Stoicea N, Kamar N, Luzum JA, Mikulik E, Bergese SD (2015) Buprenorphine: revisiting the efficacy of transdermal delivery system. Ther Deliv 6(4):419–422. doi:10.4155/tde.15.3
Grond S, Radbruch L, Lehmann KA (2000) Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl. Clin Pharmacokinet 38(1):59–89. doi:10.2165/00003088-200038010-00004
Minville V, Lubrano V, Bounes V, Pianezza A, Rabinowitz A, Gris C, Samii K, Fourcade O (2008) Postoperative analgesia after total hip arthroplasty: patient-controlled analgesia versus transdermal fentanyl patch. J Clin Anesth 20(4):280–283. doi:10.1016/j.jclinane.2007.12.013
Sathitkarnmanee T, Tribuddharat S, Noiphitak K, Theerapongpakdee S, Pongjanyakul S, Huntula Y, Thananun M (2014) Transdermal fentanyl patch for postoperative analgesia in total knee arthroplasty: a randomized double-blind controlled trial. J Pain Res 7:449–454. doi:10.2147/JPR.S66741
Sevarino FB, Paige D, Sinatra RS, Silverman DG (1997) Postoperative analgesia with parenteral opioids: does continuous delivery utilizing a transdermal opioid preparation affect analgesic efficacy or patient safety? J Clin Anesth 9(3):173–178
Lehmann LJ, DeSio JM, Radvany T, Bikhazi GB (1997) Transdermal fentanyl in postoperative pain. Reg Anesth 22(1):24–28
Kim HJ, Park JH, Kim JW, Kang KT, Chang BS, Lee CK, Yeom JS (2014) Prediction of postoperative pain intensity after lumbar spinal surgery using pain sensitivity and preoperative back pain severity. Pain Med 15(12):2037–2045. doi:10.1111/pme.12578
Rabin R, de Charro F (2001) EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33(5):337–343
Serpell M, Tripathi S, Scherzinger S, Rojas-Farreras S, Oksche A, Wilson M (2016) Assessment of transdermal buprenorphine patches for the treatment of chronic pain in a UK observational study. The Patient 9(1):35–46. doi:10.1007/s40271-015-0151-y
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was partially supported by research Grants from Mundipharma Co. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Conflict of interest
None of the authors has any potential conflict of interest.
Rights and permissions
About this article
Cite this article
Kim, HJ., Ahn, H.S., Nam, Y. et al. Comparative study of the efficacy of transdermal buprenorphine patches and prolonged-release tramadol tablets for postoperative pain control after spinal fusion surgery: a prospective, randomized controlled non-inferiority trial. Eur Spine J 26, 2961–2968 (2017). https://doi.org/10.1007/s00586-017-5213-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-017-5213-5